Syndax Pharmaceuticals annual capital expenditures (capex)
2014
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Syndax Pharmaceuticals Capital Expenditures (CapEx) Growth & History (SNDX)
Syndax Pharmaceuticals's capital expenditures (capex) was $187,000 for fiscal 2025.
View full Syndax Pharmaceuticals company overviewSyndax Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $187,000 | $187,000 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$129,000 | — |
| 2021 | 2021-12-31 | $129,000 | $129,000 | — |
| 2020 | 2020-12-31 | $0 | — | — |
| 2018 | 2018-12-31 | $187,000 | $103,000 | +122.62% |
| 2017 | 2017-12-31 | $84,000 | −$177,000 | −67.82% |
| 2016 | 2016-12-31 | $261,000 | $212,000 | +432.65% |
| 2015 | 2015-12-31 | $49,000 | $45,000 | +1125.00% |
| 2014 | 2014-12-31 | $4,000 | — | — |
Syndax Pharmaceuticals quarterly capital expenditures (capex)
Q3.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.18
Q2.18
Q3.18
Q4.18
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $56,000 | — | — |
| Q4 2018 | 2018-12-31 | $14,000 | — | — |
| Q3 2018 | 2018-09-30 | $0 | — | — |
| Q2 2018 | 2018-06-30 | $0 | — | — |
| Q1 2018 | 2018-03-31 | $173,000 | — | — |
| Q4 2016 | 2016-12-31 | $0 | — | — |
| Q3 2016 | 2016-09-30 | $55,000 | $42,000 | +323.08% |
| Q2 2016 | 2016-06-30 | $73,000 | — | — |
| Q1 2016 | 2016-03-31 | $133,000 | — | — |
| Q3 2015 | 2015-09-30 | $13,000 | — | — |
Syndax Pharmaceuticals capital expenditures (capex) trends
Over the last five fiscal years, Syndax Pharmaceuticals's capital expenditures (capex) increased from $0 to $187,000, a change of $187,000. The latest reported quarter, Q4 2025, shows $56,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Syndax Pharmaceuticals source filings ↗